Logotype for Chambal Fertilisers and Chemicals Limited

Chambal Fertilisers and Chemicals (CHAMBLFERT) Q3 25/26 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Chambal Fertilisers and Chemicals Limited

Q3 25/26 earnings summary

11 Feb, 2026

Executive summary

  • India's largest private sector urea producer, contributing 10% of domestic supply, with significant shares in crop protection chemicals, specialty nutrients, and complex fertilizers.

  • Q3 FY26 operational income rose 20% year-on-year to INR 5,898 crore, with net profit up 12% to INR 565 crore and EPS up 10% to INR 14.64; strong performance in crop protection, specialty nutrients, and biologicals.

  • Urea volumes were lower due to an unscheduled plant stoppage, but P&K fertilizers and new product launches supported results.

  • Strategic partnerships and R&D initiatives, including collaboration with TERI for sustainable agri-solutions and a dedicated lab for new product development.

  • Board approved unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, with limited review by auditors and no material misstatements identified.

Financial highlights

  • Q3 FY26 standalone revenue from operations grew 20% year-on-year to INR 5,898 crore; consolidated net profit at INR 586 crore.

  • Q3 EBITDA rose 6% to INR 821 crore, with EBITDA margin at 13.92%; PAT increased 12% to INR 565 crore, PAT margin at 9.57%.

  • Nine-month revenue up 27% year-on-year to INR 18,009 crore; EBITDA up 4% to INR 2,424 crore; PAT up 16% to INR 1,804 crore.

  • Finance costs dropped sharply to INR 42 million for 9M FY26 from INR 484 million YoY; net debt to equity remains nil as of FY25.

  • Received subsidy of INR 3,880 crore in Q3 and INR 10,228 crore for nine months; receivables at INR 2,346 crore as of Dec 31, 2025.

Outlook and guidance

  • Healthy product pipeline with 12 new CPC and one specialty nutrient product planned for FY2027; new biological products, especially fungicides and nematicides, are planned for the next financial year.

  • TAN project 92% complete, with trial runs expected in April 2026 and full ramp-up targeted for FY2027 at 75-80%+ utilization; INR 11,836 million spent till Q3 FY26.

  • Ongoing evaluation of capacity expansion in P&K fertilizers and active overseas investment discussions.

  • Incremental obligations due to new labour codes have been estimated and recognized, with ongoing monitoring for further regulatory impacts.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more